LIQUIDIA TECHNOLOGIES
Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline:... LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
LIQUIDIA TECHNOLOGIES
Industry:
Biopharma Biotechnology Nanotechnology Therapeutics
Founded:
2004-01-01
Address:
Morrisville, North Carolina, United States
Country:
United States
Website Url:
http://www.liquidia.com
Total Employee:
11+
Status:
Active
Contact:
(919)328-4400
Email Addresses:
[email protected]
Total Funding:
223.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FibroGen
FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.
Raptor Pharmaceuticals
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-06-29 | RareGen | RareGen acquired by Liquidia Technologies | N/A |
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Liquidia Technologies
Paul Manning
Paul Manning investment in Post-IPO Equity - Liquidia Technologies
Caligan Partners
Caligan Partners investment in Post-IPO Equity - Liquidia Technologies
Roger Jeffs
Roger Jeffs investment in Post-IPO Equity - Liquidia Technologies
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Liquidia Technologies
Eshelman Ventures
Eshelman Ventures investment in Post-IPO Equity - Liquidia Technologies
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Liquidia Technologies
AMDG 1
AMDG 1 investment in Post-IPO Equity - Liquidia Technologies
BKB Growth Investments
BKB Growth Investments investment in Post-IPO Equity - Liquidia Technologies
Canaan Partners
Canaan Partners investment in Post-IPO Equity - Liquidia Technologies
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-03 | Liquidia Corporation Announces Chief Executive Officer Transition |
| 2020-08-20 | Liquidia Announces Chief Financial Officer Transition |
| 2020-05-18 | Morrisville-based Liquidia names its first chief medical officer |
Official Site Inspections
http://www.liquidia.com Semrush global rank: 3.31 M Semrush visits lastest month: 4.88 K
- Host name: a23-195-37-135.deploy.static.akamaitechnologies.com
- IP address: 23.195.37.135
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Liquidia Technologies"
Liquidia Corporation - LinkedIn
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology.See details»
Liquidia Corporation (LQDA) - Yahoo Finance
See the company profile for Liquidia Corporation (LQDA) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and ...See details»
Liquidia Corporation: Shareholders Board Members Managers and …
3 days ago Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient …See details»
Liquidia Technologies - Crunchbase Company …
Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.See details»
About us | Liquidia Corporation
Guided by compassion, committed to patients We are difference makers driven to help patients with cardiopulmonary disease breathe easier and live longer. Each of us is committed to our mission to change patients’ lives …See details»
Liquidia Company Profile | Management and Employees List
Liquidia Profile and History Liquidia Technologies, Inc., a wholly owned subsidiary of Liquidia Corporation, is a late-stage clinical biopharmaceutical company focused on the development …See details»
Investors | Liquidia Corporation
3 days ago Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans …See details»
Liquidia Corporation Reports Second Quarter 2025 Financial …
Jun 30, 2025 MORRISVILLE, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients …See details»
Corporate governance | Liquidia Corporation
Corporate governance overview The Board of Directors of Liquidia Corporation (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this …See details»
Leadership | Liquidia Corporation
Harold Alterson joined Liquidia in 2025 as Senior Vice President of Quality where he oversees and directs the company's Quality organization. With more than 25 years of experience in the …See details»
Lang | Management | Liquidia Corporation
Beth Lang joined Liquidia in 2025 where she serves as Senior Vice President of Global Regulatory Affairs. Beth brings more than 25 years of extensive regulatory strategy expertise …See details»
Liquidia CSR
Liquidia is a biopharmaceutical company which core mission is to develop and deliver innovative medical products to meet unmet patient needs and help improve their lives. We are committed …See details»
Liquidia Shoots Higher As Yutrepia Launch Kicks Off Amid United …
3 days ago Liquidia stock shot higher Tuesday after its new drug, Yutrepia, widely beat prescription and patient start expectations.See details»
What is Brief History of Liquidia Technologies Company?
Jul 24, 2025 This article delves into Liquidia's history, examining its Liquidia company background, its product pipeline, and its role in Liquidia pharmaceuticals. We'll explore the …See details»
Liquidia Corporation Reports Second Quarter 2025 Financial …
3 days ago Dr. Roger Jeffs, Liquidia’s Chief Executive Officer, said: “The second quarter was a defining period for Liquidia with the FDA approval and rapid commercial launch of …See details»
Form 10-K for Liquidia Corp filed 03/19/2025
Liquidia PAH works jointly with Sandoz on commercial strategy for Treprostinil Injection and on identifying, manufacturing and developing medical devices, including pumps and cartridges, …See details»
IR Contact | Liquidia
IR Contact Questions for the Investor Relations department can be submitted using the form below or email [email protected]. For all other inquires please go to Contact Us.See details»
Liquidia CSR
Liquidia is a biopharmaceutical company which core mission is to develop and deliver innovative medical products to meet unmet patient needs and help improve their lives. We are committed …See details»
Liquidia - Crunchbase Company Profile & Funding
Liquidia is a manufacturer and distributor of automotive products and accessories.See details»
Liquidia: Uncertainty Has Always Been A Buying Opportunity
4 days ago For Liquidia, that uncertainty has always been a buying opportunity. Shares are 200% higher today than our original purchase price more than three years ago.See details»